newheader.jpg
 


Conference Menu

Overview
Day 1
Day 2
Day 3
Download PDF
Register
Hotel & Travel
Exhibit/Sponsor
Poster
Press Pass
Request Brochure
Send to a Colleague
 

PART OF:

Targeted
Immunotherapeutics 
& Vaccine Summit
August 21-23, 2006

Novel Vaccines: 
August 21-23, 2006

Targeted Cancer Therapies: 
August 21-22, 2006

Cancer Immunotherapeutics 
& Vaccines: 
August 22-23, 2006


Complimentary Article Downloads:
Pharma Prepares for Avian Flu Pandemic: While skepticism reigns, pharma readies an array of new weapons just in case 
Authored by: Malorye A. Branca and Lucy Sannes, Ph.D. 

Synthetic Peptide Vaccine Against Pandemic H5N1 Influenza Based on Li-Key Modifies MHC Class II Epitopes
Authored by: Robert E. Humphreys, John W. Zinckgraf, Naomi Jiang, Eric von Hofe*, and Douglas M. Powell 

Compliments of

Corporate Sponsors:
 
Lead Sponsoring Publication:
Sponsoring Publications:
 

Web Partners:

Overview


Novel Vaccines show promise for protecting humanity from the scourge of disease, yet their worth is not always appreciated by the public, leading to shortfalls in funding and product. This meeting features talks from leading innovators in the field of vaccines, ranging from cutting-edge research to breakthroughs in transporting and administering vaccines throughout the world. Solutions will be presented that overcome the previous limitations of producing vaccine in embryonated chicken eggs. Novel Vaccines: Bridging Research, Development, and Production will focus on a New Wave of vaccines for the 21st century.
 
Sessions Include:

Day 1: Research: Meeting Medical Needs

  • Overcoming Challenges
  • Discovering Solutions
  • Vaccine Breakthroughs

Day 2: Development: Transforming Concept into Product

  • Promising Development
  • Enhanced Magnitude & Functionality
  • Immunomodulators/Adjuvants
  • Autologus Cell Technologies
  •  

Day 3: Production: Heading to Market

  • Vaccine Production Logistics
  • Readying Vaccines for Market
  • Bringing Needed Vaccines to Patients Around The World
  • Novel Methods for Administering Vaccines
Keynote Presentations:

New Vaccine Technologies: A Regulatory Perspective
Jon R. Daugherty, Ph.D., U.S. Public Health Service, Senior Regulatory Review Officer, Office of Vaccines Research and Review, CBER / FDA

NIAID's Role in Influenza Vaccine Development
David S. Cho, Ph.D., M.P.H., Influenza Product Development Program Officer, Influenza,
SARS, & Related Viral Respiratory Diseases Section, NIAID / NIH

Featured Speakers:

Human Respiratory Virus Diseases and Vaccine Prospects
Richard Spaete, Ph.D., Senior Director, Research, MedImmune Vaccines, Inc.

Development of a Production Process for an ALVAC Vaccine Candidate
Kim Wong, Ph.D., Director, Cell & Viral Culture, Process Development, sanofi pasteur Ltd.

Adjuvanting DNA Vaccines
David B. Weiner, Ph.D., Chair, Gene Therapy and Vaccines Program, CAMB, Department of Pathology, University of Pennsylvania School of Medicine


For more information, please contact:
Mary Ruberry, Conference Producer
Phone: 781-972-5421 • E-mail: mruberry@healthtech.com  

For exhibit and sponsorship information, please contact:
Suzanne Carroll, Manager, Business Development
Phone: 781-972-5452 • E-mail: scarroll@healthtech.com

 

foot.jpg


Cambridge Healthtech Institute| Beyond Genome | Bio-IT World | Biomarker World Congress | Cambridge Health Associates | Discovery On Target |
Health-IT World
| Bio-IT World Conference & Expo  | Molecular Medicine Tri-Conference | PEGS| PepTalk | Pharma DD
World Pharmaceutical Congress |

Your  Life Science Network

Cambridge Healthtech Institute  |  250 First Avenue  |  Suite 300   |   Needham,  MA  02494
Phone: 781-972-5400  |   Fax: 781-972-5425
chi@healthtech.com